Termination of Early Pregnancy — Menstrual Induction
Suction curettage, the most prevalent technique for first trimester abortion, was developed to minimize complications of infection and blood loss encountered with dilatation and sharp curettage. Suction curettage, however, is not without immediate and future risks, including the hazards of anesthesia and the potential for cervical damage resulting from mechanical dilatation of the cervix. A desire to minimize these risks led to the development of the early suction abortion which has been variously termed menstrual regulation, menstrual extraction, and mini-abortion (Karman and Potts 1972). Later experience with this technique, however, demonstrated the routine need for local anesthesia to minimize vasovagal symptoms and in some patients mechanical cervical dilatation could not be avoided.
Unable to display preview. Download preview PDF.
- Baulieu EE (1985) An antiprogestin steroid with contragestive activity in women. In: Baulieu EE, Segal SJ (eds) The Antiprogestin steroid RU 486 and human fertility control. Plenum, New York, pp 1–6Google Scholar
- Bygdeman M, Borell U, Leader A, Lundström V, Martin JN Jr, Eneroth P, Gréen K (1976) Induction of first and second trimester abortion by the vaginal administration of 15-methyl-PGF2 methyl ester. In: Samuelsson B, Paoletti R (eds) Advances in prostaglandin and thromboxane research, vol 2. Raven, New York, pp 693–704Google Scholar
- Herrmann W, Wyss R, Riondel A, Philibert D, Teutsch G, Sekiz E, Baulieu EE (1982) Effet d’un steroid antiprogesterone chez la femme: interruption du cycle menstruel et de la grossesse au debut. CR Acad Sci [III] 294:933–938Google Scholar
- Lauersen NH (1986) Induced abortion. In: Bygdeman M, Berger GS, Keith LG (eds) Prostaglandins and their inhibitors in clinical obstetrics and gynecology. MTP Press, Lancaster, pp 271–314Google Scholar
- Swahn ML, Bygdeman M(1987) Interruption of early gestation with prostaglandins and antiprogestin. In: Diczfalusy E, Bygdeman M (eds) Fertility regulation today and tomorrow. Raven, New York (in press) Serono Symposia 36:109–118Google Scholar
- Swahn ML, Cekan S, Wang G, Lundström V, Bygdeman M (1985) Pharmacokinetic and clinical studies of RU 486 for fertility regulation. In: Baulieu EE, Segal SJ (eds) The antiprogestin steroid RU 486 and human fertility control. Plenum, New York, pp 249–258Google Scholar
- WHO Prostaglandin Task Force (1982) Termination of very early first trimester pregnancy by vaginal administration of 16,16-dimethyl-trans-Δ2-PGE1 methyl ester. Asia Oceania J Obstet Gynecol 8:263–268Google Scholar
- WHO Task Force on Post-Ovulatory Methods for Fertility Control (1987) Menstrual regulation by intramuscular injections of 16-phenocy-tetranor PGE2 methyl sulfonylamide. Br J Obstet Gynaecol (in press)Google Scholar